These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


146 related items for PubMed ID: 21979403

  • 1. An unusual complication of peptic ulcer disease: double pylorus.
    Sayilir A, Kurt M, Onal IK, Beyazit Y, Suvak B.
    Gastroenterol Nurs; 2011; 34(5):401-2. PubMed ID: 21979403
    [No Abstract] [Full Text] [Related]

  • 2. Peptic ulcer disease in patients with chronic liver disease: looking beyond bugs and drugs.
    Saad RJ, Chey WD.
    Gastrointest Endosc; 2005 Sep; 62(3):357-9. PubMed ID: 16111951
    [No Abstract] [Full Text] [Related]

  • 3. Eradication of Helicobacter pylori improves the healing rate and reduces the relapse rate of nonbleeding ulcers in patients with bleeding peptic ulcer.
    Arkkila PE, Seppälä K, Kosunen TU, Haapiainen R, Kivilaakso E, Sipponen P, Mäkinen J, Nuutinen H, Rautelin H, Färkkilä MA.
    Am J Gastroenterol; 2003 Oct; 98(10):2149-56. PubMed ID: 14572560
    [Abstract] [Full Text] [Related]

  • 4. [Double pylorus: an unusual finding in a common disease].
    Vida Pérez L, Castillo Molina L, González Galilea A, Gálvez Calderón C, De Dios Vega JF.
    Gastroenterol Hepatol; 2009 Jan; 32(1):75-6. PubMed ID: 19174111
    [No Abstract] [Full Text] [Related]

  • 5. Efficacy of Helicobacter pylori eradication therapy in chronic liver disease.
    Jung SW, Lee SW, Hyun JJ, Kim DI, Koo JS, Yim HJ, Park JJ, Lee HS, Chun HJ, Um SH, Choi JH, Kim CD, Ryu HS.
    Dig Liver Dis; 2009 Feb; 41(2):134-40. PubMed ID: 18436489
    [Abstract] [Full Text] [Related]

  • 6. H. pylori should be eradicated in chronic liver disease patients with peptic ulcer.
    Zullo A, Cristofari F, Hassan C.
    Dig Liver Dis; 2009 Feb; 41(2):141-2. PubMed ID: 19112053
    [No Abstract] [Full Text] [Related]

  • 7. Effect of Helicobacter pylori eradication and antisecretory maintenance therapy on peptic ulcer recurrence in cirrhotic patients: a prospective, cohort 2-year follow-up study.
    Tzathas C, Triantafyllou K, Mallas E, Triantafyllou G, Ladas SD.
    J Clin Gastroenterol; 2008 Jul; 42(6):744-9. PubMed ID: 18277886
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of Helicobacter pylori eradication therapy in cirrhotic patients with peptic ulcer disease.
    Mitrică D, Pleşa A, Constantinescu R, Drug V, Stanciu C.
    Rev Med Chir Soc Med Nat Iasi; 2011 Jul; 115(2):367-74. PubMed ID: 21870725
    [Abstract] [Full Text] [Related]

  • 9. [A new clinical strategy in peptic ulcer disease. Suggestions for the elimination of Helicobacter pylori].
    Unge P, Ekström P.
    Lakartidningen; 1994 May 11; 91(19):1925-32. PubMed ID: 8189937
    [No Abstract] [Full Text] [Related]

  • 10. Ten-day sequential therapy of Helicobacter pylori infection in Thailand.
    Sirimontaporn N, Thong-Ngam D, Tumwasorn S, Mahachai V.
    Am J Gastroenterol; 2010 May 11; 105(5):1071-5. PubMed ID: 20010919
    [Abstract] [Full Text] [Related]

  • 11. Peptic ulcer disease and current approaches to Helicobacter pylori.
    Hassall E.
    J Pediatr; 2001 Apr 11; 138(4):462-8. PubMed ID: 11295706
    [No Abstract] [Full Text] [Related]

  • 12. Helicobacter pylori infection does not affect the early rebleeding rate in patients with peptic ulcer bleeding after successful endoscopic hemostasis: a prospective single-center trial.
    Schilling D, Demel A, Nüsse T, Weidmann E, Riemann JF.
    Endoscopy; 2003 May 11; 35(5):393-6. PubMed ID: 12701009
    [Abstract] [Full Text] [Related]

  • 13. Ulcers and gastritis.
    Pang SH, Leung WK, Graham DY.
    Endoscopy; 2008 Feb 11; 40(2):136-9. PubMed ID: 18058616
    [No Abstract] [Full Text] [Related]

  • 14. [Management of the peptic ulcer patient in the Helicobacter pylori age].
    Marshall BJ.
    Enferm Infecc Microbiol Clin; 1994 May 11; 12 Suppl 1():36-40. PubMed ID: 7914434
    [No Abstract] [Full Text] [Related]

  • 15. Bismuth-based combination therapy for Helicobacter pylori-associated peptic ulcer disease (metronidazole for eradication, ranitidine for pain).
    Tefera S, Berstad A, Bang CJ, Nysaeter G, Hatlebakk JG, Olafsson S, Nesje LB, Hausken T, Berstad K, Hundal O.
    Am J Gastroenterol; 1996 May 11; 91(5):935-41. PubMed ID: 8633584
    [Abstract] [Full Text] [Related]

  • 16. A randomized controlled trial of test-and-treat strategy for Helicobacter pylori: clinical outcomes and health care costs in a managed care population receiving long-term acid suppression therapy for physician-diagnosed peptic ulcer disease.
    Allison JE, Hurley LB, Hiatt RA, Levin TR, Ackerson LM, Lieu TA.
    Arch Intern Med; 2003 May 26; 163(10):1165-71. PubMed ID: 12767952
    [Abstract] [Full Text] [Related]

  • 17. Prevalence of esophagitis in H. pylori-positive peptic ulcer disease and the impact of eradication therapy.
    O'Connor HJ, McGee C, Ghabash NM, Cunnane K.
    Hepatogastroenterology; 2001 May 26; 48(40):1064-8. PubMed ID: 11490801
    [Abstract] [Full Text] [Related]

  • 18. Highly significant change of the clinical course of relapsing and complicated peptic ulcer disease after cure of Helicobacter pylori infection.
    Labenz J, Börsch G.
    Am J Gastroenterol; 1994 Oct 26; 89(10):1785-8. PubMed ID: 7942667
    [Abstract] [Full Text] [Related]

  • 19. [Eradication of Helicobacter pylori in peptic ulcer and chronic gastritis. A randomized clinical trial].
    Rodríguez Hernández H, Sánchez Anguiano LF, Quiñones E.
    Rev Gastroenterol Mex; 1998 Oct 26; 63(1):21-7. PubMed ID: 10068745
    [Abstract] [Full Text] [Related]

  • 20. Current diagnosis and treatment of Helicobacter pylori.
    Youssef A, Chen YK.
    West J Med; 1994 Mar 26; 160(3):254-5. PubMed ID: 8191764
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.